欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2025, Vol. 30 ›› Issue (9): 1200-1207.doi: 10.12092/j.issn.1009-2501.2025.09.006

• 药物治疗学 • 上一篇    下一篇

间羟胺与去甲肾上腺素对高原脓毒性休克患者舌下微循环的影响及疗效的比较

何宗钊1,王皓1,郑兴1,孙斌1,邓莉2   

  1. 1青海省人民医院,西宁  810007,青海;2青海大学附属医院,西宁  810000,青海
  • 收稿日期:2024-10-31 修回日期:2025-02-26 出版日期:2025-09-26 发布日期:2025-09-09
  • 通讯作者: 邓莉,女,副主任医师,研究方向:麻醉学与微循环学。 E-mail: 541251777@qq.com
  • 作者简介:何宗钊,男,副主任医师,研究方向:急危重症与微循环学。 E-mail: 86230213@qq.com
  • 基金资助:
    青海省卫生计生系统指导性计划课题(2020-wjzdx-03);2023年度青海省“昆仑英才·高层次卫生健康人才”项目

A comparative analysis of the effects of metaraminol and norepinephrine on sublingual microcirculation in patients experiencing septic shock at high altitudes

HE Zongzhao1, WANG Hao1, ZHENG Xing1, SUN Bin1, DENG Li2   

  1. 1 Qinghai People's Hospital, Xining 810007, Qinghai, China; 2 Qinghai University Affiliated Hospital, Xining 810000, Qinghai, China
  • Received:2024-10-31 Revised:2025-02-26 Online:2025-09-26 Published:2025-09-09

摘要:

目的:比较间羟胺与去甲肾上腺素对高原脓毒性休克患者舌下微循环的影响及疗效。方法:选取青海西宁地区脓毒性休克患者46例,分为间羟胺组(M组,n=22)及去甲肾上腺素组(N组,n=24)。记录患者基础资料和急性肾损伤(AKI)、肢体远端坏死/缺血发生率及28 d生存情况;应用旁流暗视野成像(SDF)技术观察记录治疗前(T0)、治疗后24 h(T1)、治疗后48 h(T2)、治疗后72 h(T3)舌下微循环的监测指标:总血管密度(TVD)、灌注血管密度(PVD)、灌注血管比例(PPV)、微血管流量指数(MFI)、异质性指数(HI);并记录心率(HR)、平均动脉压(MAP)、血尿素氮(BUN)、血肌酐(Cr)、乳酸(Lac)等变化指标。结果:两组脓毒性休克患者基础资料和AKI发生率、肢体远端坏死/缺血发生率、28 d 生存率比较差异无统计学意义;两组脓毒性休克患者在各时间点HR、MAP、Lac各指标比较无统计学差异,两组组内对比随治疗时间推移HR、MAP、Lac各指标均能改善,差异具有统计学意义,间羟胺组较去甲肾上腺素组BUN在T3时间点偏低(P<0.05),Cr在T2、T3时间点低(P<0.05);两组脓毒性休克患者舌下微循环各指标在各时间对比均无统计学差异,同时两组组内对比随治疗时间推移TVD、PVD、PPV、MIF、HI均能改善,差异具有统计学意义。结论:间羟胺与去甲肾上腺素均能改善高原地区脓毒性休克患者大循环及舌下微循环障碍,间羟胺72 h肌酐恢复更快。

关键词: 间羟胺, 去甲肾上腺素, 舌下微循环, 高原, 脓毒性休克

Abstract:

AIM: To compare the effects and efficacy of methoxyamine and norepinephrine on sublingual microcirculation in patients with high-altitude septic shock. METHODS: A total of forty-six patients with septic shock from the Xining area of Qinghai Province were randomized into two groups: the M-hydroxylamine group (Group M, n=22) and the norepinephrine group (Group N, n=24). Baseline data as well as the incidence of acute kidney injury (AKI), distal limb necrosis/ischemia, and 28-day survival rates were documented. Sublingual microcirculation parameters were monitored and recorded at four time points: before treatment (T0), 24 hours post-treatment (T1), 48 hours post-treatment (T2), and 72 hours post-treatment (T3) using side-flow dark-field (SDF) imaging. The parameters included total vascular density (TVD), perfused vascular density (PVD), perfused vessel ratio (PPV), microvascular flow index (MFI), and heterogeneity index (HI). Additionally, changes in heart rate (HR), mean arterial pressure (MAP), blood urea nitrogen (BUN), serum creatinine (Cr), and lactate (Lac) levels were also recorded. RESULTS: There were no significant differences between the two groups in terms of baseline data, incidence of AKI, distal limb necrosis/ischemia, and 28-day survival rate. Additionally, there were no significant differences in HR, MAP, and Lac indices between the two groups at any time point. However, within-group comparisons showed that HR, MAP, and Lac indices improved over the course of treatment, with statistically significant differences. The BUN level at the T3 time point was significantly lower in the mehydroxyamine group compared to the norepinephrine group (P<0.05). Similarly, Cr levels were significantly lower at both T2 and T3 time points (P<0.05). There were no significant differences in sublingual microcirculation indices between the two groups at any time point. However, TVD, PVD, PPV, MIF, and HI in both groups improved over the course of treatment, with statistically significant differences. CONCLUSION: Both methoxyamine and norepinephrine can enhance both the macrocirculation and sublingual microcirculation in patients with septic shock at high altitudes. Additionally, methoxyamine leads to a faster recovery of creatinine levels within 72 hours.

Key words: metaraminol, Norepinephrine, sublingual microcirculation, high altitudes, septic shock

中图分类号: